OPK compared with TXMD: revenue, margins and what each company keeps, and the suppliers and customers both name

OPKOpko Health, Inc.

Mkt capRevenueRevenue

TXMDTherapeuticsMD, Inc.

Mkt capRevenueRevenue

Compare

OPKOpko Health, Inc.

TXMDTherapeuticsMD, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

OPK

1 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±21.7%▲+33.06%×1.53

Q1 FY26±22.6%▼−8.26%×0.37

Feb 27 '26±23.8%0.00%×0.00

Oct 30 '25±13.4%▲+2.10%×0.16

TXMD1 of 4 reports

0 of 1at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±18.3%▲+0.48%×0.03

= impliedOPK realized, solidTXMD realized, hatchedOne scale, both sides: full bar = 34%× = |realized| ÷ impliedSource: market data

OPKOpko Health, Inc.

1.67▲+0.40%· post 1.65

Mkt cap$1.2BRevenue$164MQ2 FY26Revenue$607MFY25

TXMDTherapeuticsMD, Inc.

1.76▼−2.22%· post 1.80

ClosedOct 30 '26

Mkt cap$21.0MRevenue$869,000Q2 FY26Revenue$3MFY25

Compare

ClosedOct 30 '26

OPKOpko Health, Inc.

TXMDTherapeuticsMD, Inc.

1.67▲+0.40%post 1.65

Price

1.76▼−2.22%post 1.80

$1.2B

Mkt cap

$21.0M

Q2 FY26$164M

Revenue

$869,000Q2 FY26

FY25$607M

Revenue

$3MFY25

OPK1.67▲+0.40%vsTXMD1.76▼−2.22%ClosedOct 30 '26